loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Drug Products containing 22523 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 VIVUS INC (6)

filter

01 CAPSULE, DELAYED RELEASE;ORAL (6)

filter

01 Blank (6)

filter

01 PANCREAZE (6)

filter

01 Blank (6)

URL Supplier Web Content
CAPSULE, DELAYED R...
149,900USP UNITS; ...
22523
PANCREAZE
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
CAPSULE, DELAYED R...
98,400USP UNITS; 1...
22523
PANCREAZE
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
CAPSULE, DELAYED R...
24,600USP UNITS; 4...
22523
PANCREAZE
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
CAPSULE, DELAYED R...
15,200USP UNITS; 2...
22523
PANCREAZE
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
CAPSULE, DELAYED R...
83,900USP UNITS; 2...
22523
PANCREAZE
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
CAPSULE, DELAYED R...
61,500USP UNITS; 1...
22523
PANCREAZE
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 22523

Looking for FDA Orange Book APPLICATION 22523 6

19

Vivus, based in U.S.A, is a pharmaceutical company.

One of their notable products is PANCRELIPASE (AMYLASE;LIPASE;PROTEASE), with a corresponding application number 22523.

With a dosage strength 149,900USP UNITS; 37,000USP UNITS; 97,300USP UNITS

Dosage Form Route CAPSULE, DELAYED RELEASE; ORAL

18

Vivus, based in U.S.A, is a pharmaceutical company.

One of their notable products is PANCRELIPASE (AMYLASE;LIPASE;PROTEASE), with a corresponding application number 22523.

With a dosage strength 98,400USP UNITS; 16,800USP UNITS; 56,800USP UNITS

Dosage Form Route CAPSULE, DELAYED RELEASE; ORAL

17

Vivus, based in U.S.A, is a pharmaceutical company.

One of their notable products is PANCRELIPASE (AMYLASE;LIPASE;PROTEASE), with a corresponding application number 22523.

With a dosage strength 24,600USP UNITS; 4,200USP UNITS; 14,200USP UNITS

Dosage Form Route CAPSULE, DELAYED RELEASE; ORAL

16

Vivus, based in U.S.A, is a pharmaceutical company.

One of their notable products is PANCRELIPASE (AMYLASE;LIPASE;PROTEASE), with a corresponding application number 22523.

With a dosage strength 15,200USP UNITS; 2,600USP UNITS; 8,800USP UNITS

Dosage Form Route CAPSULE, DELAYED RELEASE; ORAL

15

Vivus, based in U.S.A, is a pharmaceutical company.

One of their notable products is PANCRELIPASE (AMYLASE;LIPASE;PROTEASE), with a corresponding application number 22523.

With a dosage strength 83,900USP UNITS; 21,000USP UNITS; 54,700USP UNITS

Dosage Form Route CAPSULE, DELAYED RELEASE; ORAL

14

Vivus, based in U.S.A, is a pharmaceutical company.

One of their notable products is PANCRELIPASE (AMYLASE;LIPASE;PROTEASE), with a corresponding application number 22523.

With a dosage strength 61,500USP UNITS; 10,500USP UNITS; 35,500USP UNITS

Dosage Form Route CAPSULE, DELAYED RELEASE; ORAL

Post Enquiry
POST ENQUIRY